Prevalence and type distribution of human papillomavirus in cervical
adenocarcinoma in Korean women
- Author(s)
- Jong-Sup Park; Young-Tak Kim; Ahwon Lee; Yonghee Lee; Ki-Tae Kim; Chi-Heum Cho; Ho-Sun Choi; David Jenkins; Edyta C. Pirog; Anco C. Molijn; Gunasekaran Ramakrishnan; Jing Chen
- Keimyung Author(s)
- Cho, Chi Heum
- Department
- Dept. of Obstetrics & Gynecology (산부인과학)
- Journal Title
- Gynecologic Oncology
- Issued Date
- 2013
- Volume
- 130
- Issue
- 1
- Abstract
- Background. An increase in incidence of cervical adenocarcinoma (CADC) has been reported in many
countries, including Korea. However, few studies describe human papillomavirus (HPV) type distribution
among CADC in Asia.
Objective and methods. This was a retrospective, hospital-based observational study between 2005 and
2010 to estimate the overall prevalence and distribution of HPV types among CDAC in Korean women. The
study used hematoxylin & eosin and immunohistochemical staining (for the two biomarkers p16 and progesterone
receptor [PR]) to diagnose and subtype CADC samples. HPV DNA was amplified by polymerase chain
reaction (PCR) and HPV genotypes were identified using reverse hybridization.
Results. Of 196 cases submitted, 89.3% of the cases were confirmed as CADC. The mean age at diagnosis
was 47.1 (standard deviation [SD] 11.9) years. No statistically significant differences in mean age at diagnosis
by histological subtype were found. HPV DNA was detected in 90.3% (177/196) of CADC. HPV-18 was the
most prevalent type (54.2%), followed by HPV-16 (44.1%) and HPV-45 (3.4%). Infection with any high-risk
HPV type was identified in 97.7% of HPV-DNA-positive CADC. The biomarker p16 was positive in 92% of
CADC cases and PR was positive in 19.6% of CADC.
Conclusion. HPV DNA was found in the large majority of CADC in Korean women, with HPV-18 being the
most common type followed by HPV-16 and HPV-45. This study is among the first in Asia to specifically
report HPV type distribution in CADC. This information will help inform policy decisions concerning HPV
vaccination for the prevention of CADC.
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.